Harrow Health competitorsClear all
Harrow Health's top competitors include Hemogenyx Pharmaceuticals, India Globalization Capital, Tarveda Therapeutics and LTS Lohmann Therapie-Systeme.
| Save Comparison |  Harrow Health Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. |  Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company. |  India Globalization Capital India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. |  Tarveda Therapeutics Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors. |  LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances. |
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 2005 | Founding Date 2011 | Founding Date 1984 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ Roxbury Township, US Irvine, US | Locations London, GB HQ | Locations Bethesda, US HQ | Locations Watertown, US HQ | Locations Andernach, DE HQ Shanghai, CN West Caldwell, US |
Employees | Employees 1345% increase | Employees N/A | Employees 2025% increase | Employees 3417% increase | Employees N/A |
Valuation ($) | Valuation ($) 138.9 m | Valuation ($) N/A | Valuation ($) 34.4 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 518 | Twitter followers 440 | Twitter followers 1.2 k | Twitter followers N/A | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 27 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3.3 | Average likes per tweet (last 30 days) 0.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 70.37% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 1094691 | Alexa Website Rank N/A | Alexa Website Rank 1055714 | Alexa Website Rank 591942 | Alexa Website Rank 855752 |
Financial | |||||
Revenue (est.) | Revenue (est.) $41.4m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $5.1m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $16.5m (FY, 2018) | Cost of goods N/A | Cost of goods $5m (FY, 2019) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $24.9m (FY, 2018) | Gross profit N/A | Gross profit $132k (FY, 2019) | Gross profit N/A | Gross profit N/A |
Funding | |||||
Total funding raised | Total funding raised $ 48.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 158.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Hemogenyx Pharmaceuticals
HQ
London, GB
Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company.
View companyIndia Globalization Capital
HQ
Bethesda, US
Employees
20↑ 25% increase
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
View companyTarveda Therapeutics
HQ
Watertown, US
Employees
34↑ 17% increase
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.
View companyLTS Lohmann Therapie-Systeme
HQ
Andernach, DE
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
View company